Safety and Tolerability of Lu AG06474 in Healthy Young Men

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 4, 2021

Primary Completion Date

December 22, 2022

Study Completion Date

December 22, 2022

Conditions

Healthy

Interventions

DRUG

Lu AG06474

solution, orally (Parts A and B)

DRUG

Placebo

solution, orally (Part A only)

Trial Locations (1)

Quotient Sciences Miami, Miami

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY

NCT05003687 - Safety and Tolerability of Lu AG06474 in Healthy Young Men | Biotech Hunter | Biotech Hunter